Literature DB >> 8763258

Clinical significance of K-ras oncogene activation in ampullary neoplasms.

C H Chung1, R E Wilentz, M M Polak, T B Ramsoekh, L A Noorduyn, D J Gouma, K Huibregtse, G J Offerhaus, R J Slebos.   

Abstract

AIMS: To investigate the prevalence of K-ras codon 12 point mutations in ampullary neoplasms, to explore their clinical usefulness, and to test whether the detection of these mutations could be used to identify ampullary malignancies at an early stage.
METHODS: Forty one tumour specimens from 28 patients with ampullary neoplasms were analysed for activating point mutations in K-ras codon 12 using a sensitive polymerase chain reaction (PCR) based assay.
RESULTS: Eleven (39%) of the 28 primary tumours harboured point mutations in K-ras. Mutations were identified in seven (41%) of the 17 carcinomas and four (36%) of the 11 adenomas. Four of the possible six permutations in codon 12 were found in these 11 samples. This spectrum of mutations is different from pancreatic carcinoma but resembles that of colorectal neoplasms. Cytological brush specimens were available in 11 cases, and in all of these specimens, the K-ras status in the primary tumour and brush specimens was identical.
CONCLUSIONS: K-ras codon 12 point mutations occur in about 40% of ampullary neoplasms at a relatively early stage in tumorigenesis. The pattern of mutations in these tumours resembles that of the adenoma-carcinoma sequence in the colorectum. These results indicate that ampullary neoplasms can be detected at an early stage by searching for genetic alterations in the K-ras oncogene in cytological brush specimens.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8763258      PMCID: PMC500534          DOI: 10.1136/jcp.49.6.460

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  28 in total

1.  Prevalence of ras gene mutations in human colorectal cancers.

Authors:  J L Bos; E R Fearon; S R Hamilton; M Verlaan-de Vries; J H van Boom; A J van der Eb; B Vogelstein
Journal:  Nature       Date:  1987 May 28-Jun 3       Impact factor: 49.962

2.  Preoperative staging and assessment of resectability of pancreatic cancer.

Authors:  A L Warshaw; Z Y Gu; J Wittenberg; A C Waltman
Journal:  Arch Surg       Date:  1990-02

3.  Genetic alterations during colorectal-tumor development.

Authors:  B Vogelstein; E R Fearon; S R Hamilton; S E Kern; A C Preisinger; M Leppert; Y Nakamura; R White; A M Smits; J L Bos
Journal:  N Engl J Med       Date:  1988-09-01       Impact factor: 91.245

Review 4.  ras oncogenes in human cancer: a review.

Authors:  J L Bos
Journal:  Cancer Res       Date:  1989-09-01       Impact factor: 12.701

5.  Morphogenesis and possible precursor lesions of invasive carcinoma of the papilla of Vater: epithelial dysplasia and adenoma.

Authors:  K Baczako; M Büchler; H G Beger; C J Kirkpatrick; O Haferkamp
Journal:  Hum Pathol       Date:  1985-03       Impact factor: 3.466

6.  Pancreaticoduodenal resection. Surgical experience and evaluation of risk factors in 103 patients.

Authors:  J P Lerut; P R Gianello; J B Otte; P J Kestens
Journal:  Ann Surg       Date:  1984-04       Impact factor: 12.969

7.  Progression of a benign epithelial ampullary tumor to adenocarcinoma.

Authors:  D J Gouma; H Obertop; J Vismans; D Willebrand; P B Soeters
Journal:  Surgery       Date:  1987-04       Impact factor: 3.982

8.  Clinical application of ras gene mutation for diagnosis of pancreatic adenocarcinoma.

Authors:  M Tada; M Omata; M Ohto
Journal:  Gastroenterology       Date:  1991-01       Impact factor: 22.682

9.  Detection of c-Ki-ras gene codon 12 mutations from pancreatic duct brushings in the diagnosis of pancreatic tumours.

Authors:  J L Van Laethem; P Vertongen; J Deviere; J Van Rampelbergh; F Rickaert; M Cremer; P Robberecht
Journal:  Gut       Date:  1995-05       Impact factor: 23.059

10.  Radical resection for carcinoma of the ampulla of Vater.

Authors:  J R Monson; J H Donohue; G P McEntee; D C McIlrath; J A van Heerden; R G Shorter; D M Nagorney; D M Ilstrup
Journal:  Arch Surg       Date:  1991-03
View more
  11 in total

1.  Increased levels of sperm protein 17 mRNA and circulating antibodies in periampullary carcinoma patients.

Authors:  Shivam Singh; Anoop Saraya; Rinu Sharma
Journal:  Int J Clin Oncol       Date:  2014-10-29       Impact factor: 3.402

2.  Endoscopic resection of ampullary adenomas: complications and outcomes.

Authors:  Roshan Patel; Jonathan Davitte; Shyam Varadarajulu; C Mel Wilcox
Journal:  Dig Dis Sci       Date:  2011-07-15       Impact factor: 3.199

3.  Pancreatic cancer after remote peptic ulcer surgery.

Authors:  M Tascilar; B P van Rees; P D J Sturm; G N J Tytgat; R H Hruban; S N Goodman; F M Giardiello; G J A Offerhaus; A C Tersmette
Journal:  J Clin Pathol       Date:  2002-05       Impact factor: 3.411

4.  Differences in Molecular Pathologic Characteristics of Pancreatic Adenocarcinoma between Egyptian and Moroccan Patients.

Authors:  Sara Robinson; Amr Soliman; Mehdi Karkouri; Hoda Gad Omer; Joel F Greenson
Journal:  Middle East J Cancer       Date:  2010-01

5.  Comparison of the novel quantitative ARMS assay and an enriched PCR-ASO assay for K-ras mutations with conventional cytology on endobiliary brush cytology from 312 consecutive extrahepatic biliary stenoses.

Authors:  N T van Heek; S J Clayton; P D J Sturm; J Walker; D J Gouma; L A Noorduyn; G J A Offerhaus; J C Fox
Journal:  J Clin Pathol       Date:  2005-12       Impact factor: 3.411

6.  Survival in ampullary cancer: potential role of different KRAS mutations.

Authors:  Nakul P Valsangkar; Thun Ingkakul; Camilo Correa-Gallego; Mari Mino-Kenudson; Ricard Masia; Keith D Lillemoe; Carlos Fernández-del Castillo; Andrew L Warshaw; Andrew S Liss; Sarah P Thayer
Journal:  Surgery       Date:  2015-02       Impact factor: 3.982

7.  Molecular Aberrations in Periampullary Carcinoma.

Authors:  Mallika Tewari; Jyoti R Swain; V K Dixit; H S Shukla
Journal:  Indian J Surg Oncol       Date:  2017-03-21

Review 8.  [Pathogenesis and histomorphology of ampullary carcinomas and their precursor lesions. Review and individual findings].

Authors:  H-P Fischer; H Zhou
Journal:  Pathologe       Date:  2003-04-09       Impact factor: 1.011

9.  Molecular analysis of PIK3CA, BRAF, and RAS oncogenes in periampullary and ampullary adenomas and carcinomas.

Authors:  Frank Schönleben; Wanglong Qiu; John D Allendorf; John A Chabot; Helen E Remotti; Gloria H Su
Journal:  J Gastrointest Surg       Date:  2009-05-14       Impact factor: 3.452

Review 10.  Small Bowel Epithelial Precursor Lesions: A Focus on Molecular Alterations.

Authors:  Alessandro Vanoli; Federica Grillo; Daniela Furlan; Giovanni Arpa; Oneda Grami; Camilla Guerini; Roberta Riboni; Luca Mastracci; Antonio Di Sabatino
Journal:  Int J Mol Sci       Date:  2021-04-22       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.